The falling incidence of hematologic cancer after heart transplantation. [artículo]
Por: Delgado Jiménez, Juan Francisco [Cardiología]
.
Colaborador(es): Servicio de Cardiología.
Tipo de material: 
ArtículoEditor: Clinical transplantation, 2014Descripción: 28(10):1142-7.Recursos en línea: Solicitar documento Resumen: Background: A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the overall effect on incidence in the HT population.
Methods: Comparison of data from the Spanish Post-Heart-Transplantation Tumour Registry for the periods 1991-2000 and 2001-2010.
Results: The incidence among patients who underwent HT in the latter period was about half that observed in the former, with a particularly marked improvement in regard to incidence more than five yr post-HT.
Conclusions: Changes in HT patient management have jointly reduced the risk of hematologic cancer in the Spanish HT population. Long-term risk appears to have benefited more than short-term risk.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC16640 (Navegar estantería) | Disponible |
Formato Vancouver:
Crespo Leiro MG, Delgado Jiménez J, López L, Alonso Pulpón L, González Vilchez F, Almenar Bonet L et al. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014 Oct;28(10):1142-7.
PMID: 25100534
Contiene 11 referencias
Background: A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the overall effect on incidence in the HT population.
Methods: Comparison of data from the Spanish Post-Heart-Transplantation Tumour Registry for the periods 1991-2000 and 2001-2010.
Results: The incidence among patients who underwent HT in the latter period was about half that observed in the former, with a particularly marked improvement in regard to incidence more than five yr post-HT.
Conclusions: Changes in HT patient management have jointly reduced the risk of hematologic cancer in the Spanish HT population. Long-term risk appears to have benefited more than short-term risk.
No hay comentarios para este ejemplar.